<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>carmustine</title><link>http://www.unboundmedicine.com/medline/ebm/research/carmustine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917845/full_citation/Immunochemotherapy_and_Autologous_Stem_Cell_Transplantation_for_Untreated_Patients_With_Mantle_Cell_Lymphoma:_CALGB_59909_</link><description>Damon LE, Johnson JL, Niedzwiecki D, et al. <br/><span class="title">Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917845/abstract/Immunochemotherapy_and_Autologous_Stem_Cell_Transplantation_for_Untreated_Patients_With_Mantle_Cell_Lymphoma:_CALGB_59909_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917845/full_citation/Immunochemotherapy_and_Autologous_Stem_Cell_Transplantation_for_Untreated_Patients_With_Mantle_Cell_Lymphoma:_CALGB_59909_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=19917845">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19917845/Immunochemotherapy_and_Autologous_Stem_Cell_Transplantation_for_Untreated_Patients_With_Mantle_Cell_Lymphoma:_CALGB_59909_">Find Related Articles</a> </description></item><item><title>Proline Analogue of Nitrosourea as a New Cytotoxic Prodrug.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19856331/full_citation/Proline_Analogue_of_Nitrosourea_as_a_New_Cytotoxic_Prodrug_</link><description>Stankiewicz-Kranc A, Bielawska A, Bielawski K, et al. <br/><span class="title">Proline Analogue of Nitrosourea as a New Cytotoxic Prodrug. [JOURNAL ARTICLE]</span><br/><span class="source" title="Archiv der Pharmazie">Arch Pharm (Weinheim) 2009 Oct 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19856331/abstract/Proline_Analogue_of_Nitrosourea_as_a_New_Cytotoxic_Prodrug_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19856331/full_citation/Proline_Analogue_of_Nitrosourea_as_a_New_Cytotoxic_Prodrug_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/ardp.200900120">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19856331/Proline_Analogue_of_Nitrosourea_as_a_New_Cytotoxic_Prodrug_">Find Related Articles</a> </description></item><item><title>A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19817542/full_citation/A_proposed_classification_system_that_projects_outcomes_based_on_preoperative_variables_for_adult_patients_with_glioblastoma_multiforme_</link><description>Chaichana K, Parker S, Olivi A, et al. <br/><span class="title">A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of neurosurgery">J Neurosurg 2009 Oct 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19817542/abstract/A_proposed_classification_system_that_projects_outcomes_based_on_preoperative_variables_for_adult_patients_with_glioblastoma_multiforme_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19817542/full_citation/A_proposed_classification_system_that_projects_outcomes_based_on_preoperative_variables_for_adult_patients_with_glioblastoma_multiforme_">Full Citation</a> | <a href="http://thejns.org/doi/abs/10.3171/2009.9.JNS09805%3furl_ver=Z39.88-2003%26amp;rfr_id=ori:rid:crossref.org%26amp;rfr_dat=cr_pub%3dncbi.nlm.nih.gov">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19817542/A_proposed_classification_system_that_projects_outcomes_based_on_preoperative_variables_for_adult_patients_with_glioblastoma_multiforme_">Find Related Articles</a> </description></item><item><title>Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19816190/full_citation/Intralesional_Lymphokine_activated_Killer_Cells_as_Adjuvant_Therapy_for_Primary_Glioblastoma_</link><description>Dillman RO, Duma CM, Ellis RA, et al. <br/><span class="title">Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of immunotherapy (Hagerstown, Md. : 1997)">J Immunother 2009 Oct 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19816190/abstract/Intralesional_Lymphokine_activated_Killer_Cells_as_Adjuvant_Therapy_for_Primary_Glioblastoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19816190/full_citation/Intralesional_Lymphokine_activated_Killer_Cells_as_Adjuvant_Therapy_for_Primary_Glioblastoma_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19816190/Intralesional_Lymphokine_activated_Killer_Cells_as_Adjuvant_Therapy_for_Primary_Glioblastoma_">Find Related Articles</a> </description></item><item><title>Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19760777/full_citation/Autologous_stem_cell_transplant_in_a_patient_with_Down_syndrome_and_relapsed_Hodgkin_lymphoma_</link><description>Eckrich MJ, Domm J, Ho R, et al. <br/><span class="title">Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pediatric blood &amp; cancer">Pediatr Blood Cancer 2009 Jul 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19760777/abstract/Autologous_stem_cell_transplant_in_a_patient_with_Down_syndrome_and_relapsed_Hodgkin_lymphoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19760777/full_citation/Autologous_stem_cell_transplant_in_a_patient_with_Down_syndrome_and_relapsed_Hodgkin_lymphoma_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19760777/Autologous_stem_cell_transplant_in_a_patient_with_Down_syndrome_and_relapsed_Hodgkin_lymphoma_">Find Related Articles</a> </description></item><item><title>Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19723100/full_citation/Protective_mechanism_of_quercetin_and_rutin_using_glutathione_metabolism_on_HO_induced_oxidative_stress_in_HepG2_cells_</link><description>Kim GN, Jang HD <br/><span class="title">Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Annals of the New York Academy of Sciences">Ann N Y Acad Sci 2009 Aug.:530-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19723100/abstract/Protective_mechanism_of_quercetin_and_rutin_using_glutathione_metabolism_on_HO_induced_oxidative_stress_in_HepG2_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19723100/full_citation/Protective_mechanism_of_quercetin_and_rutin_using_glutathione_metabolism_on_HO_induced_oxidative_stress_in_HepG2_cells_">Full Citation</a> | <a href="http://www3.interscience.wiley.com/resolve/openurl%3fgenre=article%26amp;sid=nlm:pubmed%26amp;issn=0077-8923%26amp;date=2009%26amp;volume=1171%26amp;spage=530">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19723100/Protective_mechanism_of_quercetin_and_rutin_using_glutathione_metabolism_on_HO_induced_oxidative_stress_in_HepG2_cells_">Find Related Articles</a> </description></item><item><title>Profiling patterns of glutathione reductase inhibition by the natural product illudin S and its acylfulvene analogues.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19668867/full_citation/Profiling_patterns_of_glutathione_reductase_inhibition_by_the_natural_product_illudin_S_and_its_acylfulvene_analogues_</link><description>Liu X, Sturla SJ <br/><span class="title">Profiling patterns of glutathione reductase inhibition by the natural product illudin S and its acylfulvene analogues. [Journal Article]</span><br/><span class="source" title="Molecular bioSystems">Mol Biosyst 2009 Sep; 5(9):1013-24.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19668867/abstract/Profiling_patterns_of_glutathione_reductase_inhibition_by_the_natural_product_illudin_S_and_its_acylfulvene_analogues_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19668867/full_citation/Profiling_patterns_of_glutathione_reductase_inhibition_by_the_natural_product_illudin_S_and_its_acylfulvene_analogues_">Full Citation</a></description></item><item><title>Insights into pharmacotherapy of malignant glioma in adults.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19663635/full_citation/Insights_into_pharmacotherapy_of_malignant_glioma_in_adults_</link><description>Salvati M, D'Elia A, Formichella AI, et al. <br/><span class="title">Insights into pharmacotherapy of malignant glioma in adults. [JOURNAL ARTICLE]</span><br/><span class="source" title="Expert opinion on pharmacotherapy">Expert Opin Pharmacother 2009 Aug 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19663635/abstract/Insights_into_pharmacotherapy_of_malignant_glioma_in_adults_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19663635/full_citation/Insights_into_pharmacotherapy_of_malignant_glioma_in_adults_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19663635/Insights_into_pharmacotherapy_of_malignant_glioma_in_adults_">Find Related Articles</a> </description></item><item><title>Role of Convective Flow in Carmustine Delivery to a Brain Tumor.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19639394/full_citation/Role_of_Convective_Flow_in_Carmustine_Delivery_to_a_Brain_Tumor_</link><description>Arifin DY, Lee KY, Wang CH, et al. <br/><span class="title">Role of Convective Flow in Carmustine Delivery to a Brain Tumor. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pharmaceutical research">Pharm Res 2009 Jul 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19639394/abstract/Role_of_Convective_Flow_in_Carmustine_Delivery_to_a_Brain_Tumor_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19639394/full_citation/Role_of_Convective_Flow_in_Carmustine_Delivery_to_a_Brain_Tumor_">Full Citation</a></description></item><item><title>Prognostic impact of O(6)-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19637364/full_citation/Prognostic_impact_of_O_6__methylguanine_DNA_methyltransferase_silencing_in_patients_with_recurrent_glioblastoma_multiforme_who_undergo_surgery_and_carmustine_wafer_implantation:_a_prospective_patient_cohort_</link><description>Metellus P, Coulibaly B, Nanni I, et al. <br/><span class="title">Prognostic impact of O(6)-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer">Cancer 2009 Jul 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19637364/abstract/Prognostic_impact_of_O_6__methylguanine_DNA_methyltransferase_silencing_in_patients_with_recurrent_glioblastoma_multiforme_who_undergo_surgery_and_carmustine_wafer_implantation:_a_prospective_patient_cohort_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19637364/full_citation/Prognostic_impact_of_O_6__methylguanine_DNA_methyltransferase_silencing_in_patients_with_recurrent_glioblastoma_multiforme_who_undergo_surgery_and_carmustine_wafer_implantation:_a_prospective_patient_cohort_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/cncr.24546">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19637364/Prognostic_impact_of_O_6__methylguanine_DNA_methyltransferase_silencing_in_patients_with_recurrent_glioblastoma_multiforme_who_undergo_surgery_and_carmustine_wafer_implantation:_a_prospective_patient_cohort_">Find Related Articles</a> </description></item></channel></rss>